# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066439
Filing Date
2025-05-08
Accepted
2025-05-08 08:35:12
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sln-20250331.htm iXBRL | 10-Q | 1561656
2 | EX-31.1 | sln-ex31_1.htm | EX-31.1 | 15668
3 | EX-31.2 | sln-ex31_2.htm | EX-31.2 | 15532
4 | EX-32.1 | sln-ex32_1.htm | EX-32.1 | 10070
| Complete submission text file | 0000950170-25-066439.txt |  | 6916738

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | sln-20250331.xsd | EX-101.SCH | 1158939
70 | EXTRACTED XBRL INSTANCE DOCUMENT | sln-20250331_htm.xml | XML | 1065826

Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-39487 | Film No.: 25924069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)